Feng Xia赞助的临床试验
总计2590个结果
-
National Institute on Aging (NIA)未知
-
National Institute on Aging (NIA)未知
-
National Institute on Aging (NIA)完全的
-
Zeng ChanghaoThe First Affiliated Hospital of Zhengzhou University招聘中
-
Zeng ChanghaoThe First Affiliated Hospital of Zhengzhou University招聘中
-
Zeng ChanghaoThe First Affiliated Hospital of Zhengzhou University完全的
-
Zeng ChanghaoThe First Affiliated Hospital of Zhengzhou University撤销
-
Zeng ChanghaoThe First Affiliated Hospital of Zhengzhou University撤销
-
Zeng ChanghaoThe First Affiliated Hospital of Zhengzhou University终止
-
Zeng ChanghaoThe First Affiliated Hospital of Zhengzhou University撤销
-
Zeng ChanghaoThe First Affiliated Hospital of Zhengzhou University撤销
-
Changi General HospitalNational University Hospital, Singapore; Singapore General Hospital; Tan Tock Seng Hospital完全的
-
Liang PengGuangzhou Virotech Pharmaceutical Co., Ltd.未知晚期/转移性肝细胞癌
-
Joyce LeeTan Tock Seng Hospital; National Healthcare Group, Singapore; National University of Singapore完全的
-
Jianfeng Xie完全的
-
National Institute on Aging (NIA)完全的
-
Jianfeng XieSoutheast University, China未知Diagnostic and Prognostic Value of Combination Biomarkers in the Critically Ill Patient With Sepsis.Diagnostic and Predictive Value中国
-
National Institute on Aging (NIA)终止
-
National Institute on Aging (NIA)未知